(September 11, 2023, 10:41 AM EDT) -- WILMINGTON, Del. — A bid by Accord Healthcare Inc. for judgment on the pleadings on allegations that its abbreviated new drug application (ANDA) infringes two patents directed to technology for producing “tamper resistant” tablets failed Sept. 8 when a judge from the Federal Circuit U.S. Court of Appeals, sitting by designation in the District of Delaware, denied the request....